Score Overview
Explore the 2021 public Archive ranking →
Where Chemed Corp has ranked, year by year
Showing 5 years ranking history by HDB Score.
Reached the top 50 on HDB Score in 1 year, the longest run being 1 in a row — but not in 2021.
- CHE
1996: 72.6% · 2021: 18.1% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 512.05 | — |
1 Year2025-09-29 | $ 449.73 | 13.86% |
5 Years2021-09-29 | $ 460.75 | 11.13% |
10 Years2016-09-29 | $ 134.23 | 281.47% |
20 Years2006-09-29 | $ 28.62 | 17x |
30 Years1996-09-27 | $ 12.83 | 39x |
All Time1973-05-03 | $ 2.50 | 204x |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | 30 Years1996-09-27 | All Time1973-05-03 |
|---|---|---|---|---|---|---|---|
| Price | $ 512.05 | $ 449.73 | $ 460.75 | $ 134.23 | $ 28.62 | $ 12.83 | $ 2.50 |
| Return | — | 13.86% | 11.13% | 281.47% | 17x | 39x | 204x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 2.59B | $ 274M | $ 40M |
| 2025 | $ 2.52B | $ 265M | $ 74M |
| 2024 | $ 2.43B | $ 301M | $ 178M |
| 2023 | $ 2.26B | $ 272M | $ 263M |
| 2022 | $ 2.13B | $ 249M | $ 74M |
| 2021 | $ 2.13B | $ 268M | $ 32M |
| 2020 | $ 2.07B | $ 319M | $ 162M |
| 2019 | $ 1.93B | $ 219M | $ 6M |
| 2018 | $ 1.78B | $ 205M | $ 4M |
| 2017 | $ 1.66B | $ 98M | $ 11M |
| 2016 | $ 1.57B | $ 108M | $ 15M |
| 2015 | $ 1.54B | $ 110M | $ 14M |
| 2014 | $ 1.45B | $ 99M | $ 14M |
| 2013 | $ 1.41B | $ 77M | $ 84M |
| 2012 | $ 1.43B | $ 89M | $ 69M |
| 2011 | $ 1.35B | $ 85M | $ 38M |
| 2010 | $ 1.28B | $ 81M | $ 49M |
| 2009 | $ 1.19B | $ 73M | $ 112M |
| 2008 | $ 1.14B | $ 71M | $ 3M |
| 2007 | $ 1.10B | $ 63M | $ 4M |
| 2006 | $ 1.01B | $ 50M | $ 29M |
| 2005 | $ 915M | $ 35M | $ 57M |
| 2004 | $ 734M | $ 27M | $ 71M |
| 2003 | $ 260M | -$ 3M | $ 50M |
| 2002 | $ 253M | -$ 1M | $ 37M |
| 2001 | $ 337M | -$ 10M | $ 9M |
| 2000 | $ 355M | $ 20M | $ 10M |
| 1999 | $ 453M | $ 19M | $ 17M |
| 1998 | $ 381M | $ 19M | $ 41M |
| 1997 | $ 341M | $ 30M | $ 71M |
| 1996 | $ 301M | $ 32M | $ 11M |
| 1995 | $ 699M | $ 23M | $ 19M |
| 1994 | $ 645M | $ 43M | $ 4M |
| 1993 | $ 525M | $ 19M | $ 14M |
| 1992 | $ 401M | $ 15M | $ 14M |
| 1991 | $ 352M | $ 52M | $ 5M |
| 1990 | $ 599M | $ 16M | $ 1M |
| 1989 | $ 591M | $ 26M | $ 3M |
| 1988 | $ 500M | $ 21M | $ 4M |
| 1987 | $ 391M | $ 20M | $ 4M |
| 1986 | $ 359M | $ 36M | $ 25M |
| 1985 | $ 372M | $ 21M | $ 6M |
Chemed Corp fundamental performance
Between 2005 and 2025, revenue grew from $ 915M to $ 2.52B and net income grew from $ 35M to $ 265M. Revenue increased in 18 of those 20 years; net income in 14.
Across Chemed Corp's full reported history, from 1985 to 2025, revenue grew from $ 372M to $ 2.52B and net income grew from $ 21M to $ 265M. Revenue increased in 80% of the years measured; net income in 63%.
Chemed Corp currently holds a 20-year HDB Score of 7.7 out of 10. How the HDB Score is calculated.
Membership
Continue CHE’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
